Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,224,502 | 1,238,008 | 959,038 | 1,062,481 | 1,119,503 |
| Marketable Securities | 5,766 | 5,889 | 6,838 | 73,583 | 94,095 |
| Receivables | 971,653 | 945,261 | 990,426 | 1,004,593 | 919,850 |
| Inventories | 429,618 | 470,254 | 488,279 | 512,299 | 349,432 |
| Other current assets | 184,712 | 199,675 | 223,505 | 197,756 | 206,568 |
| TOTAL | $2,816,249 | $2,859,087 | $2,668,085 | $2,850,712 | $2,689,447 |
| Non-Current Assets | |||||
| PPE Net | 661,063 | 698,129 | 715,778 | 704,438 | 717,396 |
| Investments And Advances | 685,191 | 660,967 | 674,606 | 784,225 | 840,046 |
| Intangibles | 2,543,704 | 2,604,271 | 2,626,161 | 2,489,553 | 2,457,674 |
| Other Non-Current Assets | 342,369 | 375,441 | 378,140 | 314,285 | 306,357 |
| TOTAL | $4,232,326 | $4,338,808 | $4,394,686 | $4,292,501 | $4,321,473 |
| Total Assets | $7,048,581 | $7,197,895 | $7,062,764 | $7,143,207 | $7,010,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 205,673 | 204,000 | 207,000 | 198,000 | 201,000 |
| Accounts payable and accrued liabilities | 411,424 | 444,156 | 435,714 | 403,418 | 394,543 |
| Other current liabilities | 176,722 | 155,271 | 172,769 | 168,227 | 125,645 |
| TOTAL | $931,223 | $955,720 | $893,246 | $804,131 | $835,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | 536,250 | 612,000 | 672,750 | 742,500 | 804,000 |
| Other Non-Current Liabilities | 70,818 | 73,773 | 76,404 | 83,543 | 84,413 |
| TOTAL | $622,538 | $720,589 | $798,965 | $917,202 | $895,348 |
| Total Liabilities | $1,553,754 | $1,676,309 | $1,692,211 | $1,721,339 | $1,730,577 |
| Shareholders' Equity | |||||
| Common Shares | 112,827 | 118,034 | 119,770 | 114,563 | 116,299 |
| Retained earnings | 5,367,330 | 5,538,872 | 5,450,862 | 5,224,620 | 5,312,939 |
| Other shareholders' equity | 309,186 | 172,965 | 114,385 | 383,461 | 157,131 |
| TOTAL | $5,494,820 | $5,521,586 | $5,370,560 | $5,421,867 | $5,280,337 |
| Total Liabilities And Equity | $7,048,574 | $7,197,895 | $7,062,771 | $7,143,206 | $7,010,914 |